Przejdź do treści
  • Home
  • How we predict
  • R&D Sevices
    • GI conditions
    • Formulation behaviour
    • Molecules & Biomolecules
    • Patients and bioequivalence
  • Platforms & Software
    • Hardware
      • AMP
      • PhysioCell
      • PhysioGrad
      • DoSampler
      • loVol
    • Software
      • Compass
      • Ladme
  • About
    • About
    • Our team
  • Contact
  • Home
  • How we predict
  • R&D Sevices
    • GI conditions
    • Formulation behaviour
    • Molecules & Biomolecules
    • Patients and bioequivalence
  • Platforms & Software
    • Hardware
      • AMP
      • PhysioCell
      • PhysioGrad
      • DoSampler
      • loVol
    • Software
      • Compass
      • Ladme
  • About
    • About
    • Our team
  • Contact
Learn more

Dzień: 2026-08-24

CPHI 2026, Milan, Italy

Our CEO, Grzegorz Garbacz has been invited to speak at the Controlled Release Society

R&D Services:

  • GI conditions
  • Formulation behaviour
  • Molecules & Biomolecules
  • Patients and bioequivalence
  • GI conditions
  • Formulation behaviour
  • Molecules & Biomolecules
  • Patients and bioequivalence

Products:

  • AMP®
  • IoVol®
  • Physio Cell®
  • Physio Grad®
  • Compass®
  • DoSampler®
  • Ladme®
  • Compass®
  • AMP®
  • IoVol®
  • Physio Cell®
  • Physio Grad®
  • Compass®
  • DoSampler®
  • Ladme®
  • Compass®

Contact:

Physiolution:
Physiolution Polska sp. z o. o. 
Piłsudskiego 74/51B
50-020 Wrocław, Poland

info@physiolution.pl

g.garbacz@physiolution.pl

t: 0048 71 3357648

Created by GCDS 2026

Created by GCDS 2026